Medical Leverage Becomes CLSA Member to Expand Support of Medical Communications for Life Sciences in California
LOS ANGELES, CA – – Medical Leverage (ML) has been providing full-service, medical communication solutions to pharmaceutical, biotech, and medical device and diagnostic companies for over 18 years. Today, ML is proud to announce that they are deepening their commitment to serving the life sciences community in California by becoming a member of the California Life Sciences Association (CLSA). “The audience synergies between CLSA and Medical Leverage are significant. And, our purpose of belonging to an ecosystem that promotes partnership, education and solutions meant to advance medicine and transform healthcare made membership an easy decision,” says Medical Leverage president, Dave Oury.
In 2001, Dave began Medical Leverage after 13 years as a senior sales and marketing leader for a major pharmaceutical company. He saw a need for a medical communications company to be rooted with people and experts who had experience both buying the service, and providing the service, to life science companies and healthcare providers. “The goal from the beginning was, and has remained, to be an extension of the client’s team. A solutions-based supplier, who does not have to be told what to do next,” says Oury.
As of 2018, Medical Leverage has gained the trust of numerous clients from around the world, and their sales, training, marketing, and medical teams. They know that behind every product there is a patient, and behind every educational program there is a professional. “Our goal is for our clients, and the client’s customers, to experience the ML Wow Factor for each project,” says Oury.
About Medical Leverage
Medical Leverage is a privately-held company with headquarters in Cary, NC near Research Triangle Park, and with a West Coast office in Los Angeles, CA. For more information, please visit www.medicalleverage.com.
(800) 223.5731, ext. 509